These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38963885)

  • 41. Strengthening regulatory capacity for gene drives in Africa: leveraging NEPAD's experience in establishing regulatory systems for medicines and GM crops in Africa.
    Glover B; Akinbo O; Savadogo M; Timpo S; Lemgo G; Sinebo W; Akile S; Obukosia S; Ouedraogo J; Ndomondo-Sigonda M; Koch M; Makinde D; Ambali A
    BMC Proc; 2018; 12(Suppl 8):11. PubMed ID: 30079102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Biosafety assessment of genetically engineered animals: a review].
    Xu J; Li N
    Sheng Wu Gong Cheng Xue Bao; 2012 Mar; 28(3):267-81. PubMed ID: 22712386
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Canadian regulatory aspects of gene editing technologies.
    Ellens KW; Levac D; Pearson C; Savoie A; Strand N; Louter J; Tibelius C
    Transgenic Res; 2019 Aug; 28(Suppl 2):165-168. PubMed ID: 31321700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toward a workable biosafety system for regulating genetically modified organisms in Ethiopia: balancing conservation and competitiveness.
    Abraham A
    GM Crops Food; 2013; 4(1):28-35. PubMed ID: 23580251
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulatory and Policy Considerations Around Genome Editing in Agriculture.
    Friedrichs S; Ludlow K; Kearns P
    Methods Mol Biol; 2022; 2495():327-366. PubMed ID: 35696041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Putting Cartagena into practice.
    Watanabe KN; Taeb M; Okusu H
    Nat Biotechnol; 2004 Oct; 22(10):1207-8. PubMed ID: 15470448
    [No Abstract]   [Full Text] [Related]  

  • 47. Concern about Japan's unclear biotech regulations.
    Watanabe KN
    Nature; 2003 Feb; 421(6924):689. PubMed ID: 12610594
    [No Abstract]   [Full Text] [Related]  

  • 48. Political will to lift the GMO moratorium emerging in Europe.
    Meldolesi A
    Nat Biotechnol; 2002 Aug; 20(8):758-9. PubMed ID: 12147986
    [No Abstract]   [Full Text] [Related]  

  • 49. Regulatory challenges for GM crops in developing economies: the African experience.
    Nang'ayo F; Simiyu-Wafukho S; Oikeh SO
    Transgenic Res; 2014 Dec; 23(6):1049-55. PubMed ID: 24821674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesizing Manifested Biology.
    Pavlovich MJ
    Trends Biotechnol; 2018 Sep; 36(9):867-868. PubMed ID: 30054057
    [No Abstract]   [Full Text] [Related]  

  • 51. [Genetically modified food--unnecessary controversy?].
    Tchórz M; Radoniewicz-Chagowska A; Lewandowska-Stanek H; Szponar E; Szponar J
    Przegl Lek; 2012; 69(8):498-502. PubMed ID: 23243917
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Policy Considerations Regarding Genome Editing.
    Friedrichs S; Takasu Y; Kearns P; Dagallier B; Oshima R; Schofield J; Moreddu C
    Trends Biotechnol; 2019 Oct; 37(10):1029-1032. PubMed ID: 31229272
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clarifying the regulation of genome editing in Australia: situation for genetically modified organisms.
    Thygesen P
    Transgenic Res; 2019 Aug; 28(Suppl 2):151-159. PubMed ID: 31321698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetically modified crops: success, safety assessment, and public concern.
    Singh OV; Ghai S; Paul D; Jain RK
    Appl Microbiol Biotechnol; 2006 Aug; 71(5):598-607. PubMed ID: 16639559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulating innovative crop technologies in Canada: the case of regulating genetically modified crops.
    Smyth S; McHughen A
    Plant Biotechnol J; 2008 Apr; 6(3):213-25. PubMed ID: 18028290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic engineering: unnatural selection.
    Snow A
    Nature; 2003 Aug; 424(6949):619. PubMed ID: 12904767
    [No Abstract]   [Full Text] [Related]  

  • 57. Editing EU legislation to fit plant genome editing: The use of genome editing technologies in plant breeding requires a novel regulatory approach for new plant varieties that involves farmers.
    Ricroch AE; Ammann K; Kuntz M
    EMBO Rep; 2016 Oct; 17(10):1365-1369. PubMed ID: 27629042
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of GMOs (genetically modified organisms): agricultural biotechnology or agricultural biopolitics?
    Nuti M; Felici C; Agnolucci M
    Riv Biol; 2007; 100(2):189-202. PubMed ID: 17987558
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conservation biology, genetically modified organisms, and the biosafety protocol.
    Hill R; Sendashonga C
    Conserv Biol; 2006 Dec; 20(6):1620-5. PubMed ID: 17181797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene technology regulation in Australia: a decade of a federal implementation of a statutory legal code in a context of constituent states taking divergent positions.
    Tribe D
    GM Crops Food; 2012; 3(1):21-9. PubMed ID: 22614636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.